SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-19-002797
Filing Date
2019-08-30
Accepted
2019-08-30 17:28:34
Documents
3
Effectiveness Date
2019-08-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE INFORMATION STATEMENT phio_defa.htm DEFA14A 15867
2 GRAPHIC image_001.jpg GRAPHIC 96164
3 GRAPHIC image_002.jpg GRAPHIC 84240
  Complete submission text file 0001683168-19-002797.txt   265692
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36304 | Film No.: 191070281
SIC: 2834 Pharmaceutical Preparations